DOSAGE FORMS OF TISSUE KALLIKREIN 1

Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 µg/kg to about 10.0 µg/kg, including subcutaneous and intravenous dosage forms. Also provided are related devices and methods of use thereof, for example, for trea...

Full description

Saved in:
Bibliographic Details
Main Authors PAULS, Rick, VERDOORN, Todd
Format Patent
LanguageEnglish
French
Published 13.09.2018
Subjects
Online AccessGet full text

Cover

Loading…